• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗TNF生物制剂对白塞病患者葡萄膜炎严重程度的影响:系统评价与Meta分析。

Effects of anti-TNF biologic drugs on uveitis severity in Behçet patients: systematic review and Meta-analysis.

作者信息

Abolhasani Somayeh, Khabbazi Alireza, Hosseini Foroogh, Gholizadeh-Ghaleh Aziz Shiva, Alipour Shahriar

机构信息

Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia 5756115111, Iran.

Student Research Committee, Urmia University of Medical Sciences, Urmia 5756115111, Iran.

出版信息

Int J Ophthalmol. 2022 May 18;15(5):813-819. doi: 10.18240/ijo.2022.05.19. eCollection 2022.

DOI:10.18240/ijo.2022.05.19
PMID:35601158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9091884/
Abstract

AIM

To investigate effects of anti-TNF biologic drugs on uveitis severity (comparing visual acuity logMAR levels) in Behçet patients.

METHODS

Three databases PubMed, Scopus, and the Web of Science were searched for qualified papers focusing on the anti-TNF-α factors treatment in Behçet's disease (BD)-associated uveitis. Studies that were designed pre and post anti-TNF drug treatment, were selected. After determining the search strategy for this study, the relevant data were extracted.

RESULTS

The initial search was performed in the target databases and a total of about 1458 articles were found. Fifteen articles were selected for systematic review and only 12 of them had inclusion criteria for Meta-analysis (with visual acuity data). The mean dose of prednisolone before and after biological treatments was reported in 5 studies (28.56 and 7.56 mg/kg, respectively). Also, the preliminary results indicate a significant reduction in visual acuity logMAR levels (MD=-1.5 IU/L, 95%CI: -2.1, -0.01).

CONCLUSION

Biological drugs significantly reduce the dose of prednisolone and affect visual acuity values.

摘要

目的

研究抗TNF生物药物对白塞病患者葡萄膜炎严重程度的影响(比较最小分辨角对数视力水平)。

方法

检索三个数据库(PubMed、Scopus和科学网),查找关注抗TNF-α因子治疗白塞病(BD)相关性葡萄膜炎的合格论文。选择在抗TNF药物治疗前后设计的研究。确定本研究的检索策略后,提取相关数据。

结果

在目标数据库中进行了初步检索,共找到约1458篇文章。选择了15篇文章进行系统评价,其中只有12篇符合Meta分析的纳入标准(有视力数据)。5项研究报告了生物治疗前后泼尼松龙的平均剂量(分别为28.56和7.56mg/kg)。此外,初步结果表明最小分辨角对数视力水平显著降低(MD=-1.5IU/L,95%CI:-2.1,-0.01)。

结论

生物药物显著降低泼尼松龙剂量并影响视力值。

相似文献

1
Effects of anti-TNF biologic drugs on uveitis severity in Behçet patients: systematic review and Meta-analysis.抗TNF生物制剂对白塞病患者葡萄膜炎严重程度的影响:系统评价与Meta分析。
Int J Ophthalmol. 2022 May 18;15(5):813-819. doi: 10.18240/ijo.2022.05.19. eCollection 2022.
2
Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.儿童贝赫切特病的生物药物治疗:已发表数据的综合分析。
BioDrugs. 2023 Nov;37(6):813-828. doi: 10.1007/s40259-023-00613-6. Epub 2023 Jun 29.
3
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.抗TNF-α治疗白塞病所致难治性葡萄膜炎:124例患者的1年随访研究
Rheumatology (Oxford). 2014 Dec;53(12):2223-31. doi: 10.1093/rheumatology/keu266. Epub 2014 Jul 4.
4
Long-term efficacy, safety, and cumulative retention rate of antitumor necrosis factor-alpha treatment for patients with Behcet's uveitis: A systematic review and meta-analysis.抗肿瘤坏死因子-α治疗 Behcet 葡萄膜炎患者的长期疗效、安全性和累积保留率:系统评价和荟萃分析。
Int J Rheum Dis. 2024 Feb;27(2):e15096. doi: 10.1111/1756-185X.15096.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.抗肿瘤坏死因子α制剂对不同病因小儿葡萄膜炎治疗结果的影响。
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):801-808. doi: 10.1007/s00417-018-3928-6. Epub 2018 Feb 18.
7
Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.七例白塞氏葡萄膜炎患者的抗TNF-α治疗:优势与争议点
Ann N Y Acad Sci. 2007 Sep;1110:474-84. doi: 10.1196/annals.1423.050.
8
Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet's disease associated uveitis: a systematic review.生物疗法与合成免疫调节剂或安慰剂治疗 Behçet 病相关性葡萄膜炎的疗效和安全性的系统评价。
Rheumatol Int. 2019 Jan;39(1):47-58. doi: 10.1007/s00296-018-4193-z. Epub 2018 Nov 12.
9
Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet's disease: A systematic review of controlled trials.与传统疗法相比,抗肿瘤坏死因子-α药物治疗可降低白塞病患者葡萄膜炎的复发率:对照试验的系统评价
Front Pharmacol. 2022 Aug 19;13:912906. doi: 10.3389/fphar.2022.912906. eCollection 2022.
10
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.抗 TNF-α 治疗对 Behcet 病葡萄膜炎患者 Th17 分化的抑制作用。
Arthritis Res Ther. 2012 May 1;14(3):R99. doi: 10.1186/ar3824.

引用本文的文献

1
Shaping the Future of Behçet's Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies.塑造白塞氏葡萄膜炎治疗的未来:生物疗法的疗效、挑战与前景综合综述
Ophthalmol Ther. 2023 Oct;12(5):2295-2321. doi: 10.1007/s40123-023-00767-0. Epub 2023 Jul 21.
2
Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.儿童贝赫切特病的生物药物治疗:已发表数据的综合分析。
BioDrugs. 2023 Nov;37(6):813-828. doi: 10.1007/s40259-023-00613-6. Epub 2023 Jun 29.

本文引用的文献

1
Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets' Disease-Associated Uveitis: A Systematic Review and Meta-Analysis.抗肿瘤坏死因子-α制剂治疗白塞病相关性葡萄膜炎的有效性和安全性:一项系统评价和Meta分析
Front Pharmacol. 2020 Jun 24;11:941. doi: 10.3389/fphar.2020.00941. eCollection 2020.
2
The methylation status of TNF-α and SOCS3 promoters and the regulation of these gene expressions in patients with Behçet's disease.TNF-α 和 SOCS3 启动子的甲基化状态及这些基因在白塞病患者中的表达调控。
Biomarkers. 2020 Jul;25(5):384-390. doi: 10.1080/1354750X.2020.1754912. Epub 2020 Jun 1.
3
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis.阿达木单抗治疗威胁视力的儿童或青少年白塞病相关葡萄膜炎的经验。
J Ophthalmic Inflamm Infect. 2019 Jul 31;9(1):14. doi: 10.1186/s12348-019-0181-z.
4
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases.比较研究英夫利昔单抗与阿达木单抗治疗白塞病难治性葡萄膜炎:全国多中心 177 例研究。
Arthritis Rheumatol. 2019 Dec;71(12):2081-2089. doi: 10.1002/art.41026. Epub 2019 Oct 21.
5
Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.英夫利昔单抗治疗难治性白塞病相关性葡萄膜炎的长期疗效及治疗结果的预测因素
Eur J Rheumatol. 2018 Mar;5(1):9-15. doi: 10.5152/eurjrheum.2017.17068.
6
Methylation status of interleukin-6 gene promoter in patients with Behçet's disease.白塞病患者白细胞介素 6 基因启动子甲基化状态。
Reumatol Clin (Engl Ed). 2020 May-Jun;16(3):229-234. doi: 10.1016/j.reuma.2018.06.006. Epub 2018 Jul 31.
7
Anti-TNF Therapy in Crohn's Disease.抗 TNF 治疗克罗恩病。
Int J Mol Sci. 2018 Jul 31;19(8):2244. doi: 10.3390/ijms19082244.
8
Hypermethylation of IL-10 gene is responsible for its low mRNA expression in Behçet's disease.白塞病中 IL-10 基因的高甲基化导致其 mRNA 表达降低。
J Cell Biochem. 2018 Aug;119(8):6614-6622. doi: 10.1002/jcb.26809. Epub 2018 May 2.
9
The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.抗肿瘤坏死因子α制剂对不同病因小儿葡萄膜炎治疗结果的影响。
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):801-808. doi: 10.1007/s00417-018-3928-6. Epub 2018 Feb 18.
10
Behçet disease: New aspects.白塞病:新进展
Clin Dermatol. 2017 Sep-Oct;35(5):421-434. doi: 10.1016/j.clindermatol.2017.06.004. Epub 2017 Jun 27.